Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

rIL-2 Activated Allogeneic Lymphocytes for the Induction of Graft Versus Tumor Effect (GVT) in Metastatic Solid Tumors

NCT00855452 is registered in ClinicalTrials.gov with Hadassah Medical Organization as lead sponsor.

NCT NCT00855452
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00855452 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
rIL-2 Activated Allogeneic Lymphocytes for the Induction of Graft Versus Tumor Effect (GVT) in Metastatic Solid Tumors
Lead sponsor
Hadassah Medical Organization
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2009
Completion date
May 31, 2014
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastrointestinal cancer, malignant melanoma, metastatic breast cancer, renal cell cancer